|Bid||5.32 x 1100|
|Ask||5.40 x 1000|
|Day's Range||5.20 - 6.08|
|52 Week Range||5.20 - 55.20|
|Beta (3Y Monthly)||2.56|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Nano-cap biotech Xenetic Biosciences Inc (NASDAQ: XBIO )'s stock was rallying Friday following an announcement concerning pricing for its previously announced offering of common stock and accompanying ...
Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Anyone who held...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 13) BioSig Technologies Inc (NASDAQ: BSGM ) Milestone Pharmaceuticals ...
Xenetic Biosciences Inc (NASDAQ:XBIO), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is XBIO Read More...
Nanocap stocks are inherently risky in the stock market, but can certainly pay off for speculators when they go up. Xenetic Biosciences Inc. (NASDAQ:XBIO) surged 28%, up twofold from the $2 level the stock has been stuck at over the last year. At a closing price of $4.08 on Monday, Aug. 13, XBIO stock is still well below the $8.95 intraday high set in late-June.